MR imaging of the stomach

Potential use for mangafodipir trisodium - A study in swine

Chun S. Zuo, Peter R. Seoane, Jiani Hu, Philip P. Harnish, Neil M. Rofsky

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

PURPOSE: To evaluate mangafodipir trisodium as a potential contrast agent at magnetic resonance (MR) imaging of the stomach. MATERIALS AND METHODS: Mangafodipir trisodium was injected intravenously into three swine at a dose of 5 μmol per kilogram of body weight. For comparison, gadopentetate dimeglumine was injected into three other swine at a dose of 0.1 mmol per kilogram of body weight. T1-weighted three-dimensional MR images were acquired in all six swine at 1.5 T before and approximately 10, 15, 20, 25, 30, and 40 minutes after contrast material administration. Extracted stomach specimens were imaged at 3.0 T. In vivo and ex vivo images were evaluated visually and quantitatively for contrast enhancement of the stomach, and in vivo images were evaluated for the presence of reflux from the duodenum. RESULTS: Mangafodipir trisodium produced prolonged and selective enhancement of the inner surface of the stomach, in contrast to the more general enhancement seen with gadopentetate dimeglumine, and reflux from the duodenum could not account for this selective enhancement. Ex vivo images confirmed that T1 enhancement in the stomach wall with mangafodipir trisodium was limited to the inner surface. Gadopentetate dimeglumine did not produce selective enhancement of the inner surface of the stomach. CONCLUSION: Mangafodipir trisodium preferentially enhances the inner surface of the stomach on MR images acquired in swine and, therefore, may have potential for use as a contrast agent at MR imaging of the human stomach.

Original languageEnglish (US)
Pages (from-to)160-163
Number of pages4
JournalRadiology
Volume232
Issue number1
DOIs
StatePublished - Jul 2004

Fingerprint

Stomach
Swine
Magnetic Resonance Imaging
Gadolinium DTPA
Contrast Media
Duodenum
Magnetic Resonance Spectroscopy
Body Weight
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid

Keywords

  • Animals
  • Experimental study
  • Magnetic resonance (MR), contrast media
  • Stomach, MR
  • Stomach, mucosa

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

MR imaging of the stomach : Potential use for mangafodipir trisodium - A study in swine. / Zuo, Chun S.; Seoane, Peter R.; Hu, Jiani; Harnish, Philip P.; Rofsky, Neil M.

In: Radiology, Vol. 232, No. 1, 07.2004, p. 160-163.

Research output: Contribution to journalArticle

Zuo, Chun S. ; Seoane, Peter R. ; Hu, Jiani ; Harnish, Philip P. ; Rofsky, Neil M. / MR imaging of the stomach : Potential use for mangafodipir trisodium - A study in swine. In: Radiology. 2004 ; Vol. 232, No. 1. pp. 160-163.
@article{7d0fd91bd99148c9bf5b93c10ab69fa2,
title = "MR imaging of the stomach: Potential use for mangafodipir trisodium - A study in swine",
abstract = "PURPOSE: To evaluate mangafodipir trisodium as a potential contrast agent at magnetic resonance (MR) imaging of the stomach. MATERIALS AND METHODS: Mangafodipir trisodium was injected intravenously into three swine at a dose of 5 μmol per kilogram of body weight. For comparison, gadopentetate dimeglumine was injected into three other swine at a dose of 0.1 mmol per kilogram of body weight. T1-weighted three-dimensional MR images were acquired in all six swine at 1.5 T before and approximately 10, 15, 20, 25, 30, and 40 minutes after contrast material administration. Extracted stomach specimens were imaged at 3.0 T. In vivo and ex vivo images were evaluated visually and quantitatively for contrast enhancement of the stomach, and in vivo images were evaluated for the presence of reflux from the duodenum. RESULTS: Mangafodipir trisodium produced prolonged and selective enhancement of the inner surface of the stomach, in contrast to the more general enhancement seen with gadopentetate dimeglumine, and reflux from the duodenum could not account for this selective enhancement. Ex vivo images confirmed that T1 enhancement in the stomach wall with mangafodipir trisodium was limited to the inner surface. Gadopentetate dimeglumine did not produce selective enhancement of the inner surface of the stomach. CONCLUSION: Mangafodipir trisodium preferentially enhances the inner surface of the stomach on MR images acquired in swine and, therefore, may have potential for use as a contrast agent at MR imaging of the human stomach.",
keywords = "Animals, Experimental study, Magnetic resonance (MR), contrast media, Stomach, MR, Stomach, mucosa",
author = "Zuo, {Chun S.} and Seoane, {Peter R.} and Jiani Hu and Harnish, {Philip P.} and Rofsky, {Neil M.}",
year = "2004",
month = "7",
doi = "10.1148/radiol.2321030876",
language = "English (US)",
volume = "232",
pages = "160--163",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "1",

}

TY - JOUR

T1 - MR imaging of the stomach

T2 - Potential use for mangafodipir trisodium - A study in swine

AU - Zuo, Chun S.

AU - Seoane, Peter R.

AU - Hu, Jiani

AU - Harnish, Philip P.

AU - Rofsky, Neil M.

PY - 2004/7

Y1 - 2004/7

N2 - PURPOSE: To evaluate mangafodipir trisodium as a potential contrast agent at magnetic resonance (MR) imaging of the stomach. MATERIALS AND METHODS: Mangafodipir trisodium was injected intravenously into three swine at a dose of 5 μmol per kilogram of body weight. For comparison, gadopentetate dimeglumine was injected into three other swine at a dose of 0.1 mmol per kilogram of body weight. T1-weighted three-dimensional MR images were acquired in all six swine at 1.5 T before and approximately 10, 15, 20, 25, 30, and 40 minutes after contrast material administration. Extracted stomach specimens were imaged at 3.0 T. In vivo and ex vivo images were evaluated visually and quantitatively for contrast enhancement of the stomach, and in vivo images were evaluated for the presence of reflux from the duodenum. RESULTS: Mangafodipir trisodium produced prolonged and selective enhancement of the inner surface of the stomach, in contrast to the more general enhancement seen with gadopentetate dimeglumine, and reflux from the duodenum could not account for this selective enhancement. Ex vivo images confirmed that T1 enhancement in the stomach wall with mangafodipir trisodium was limited to the inner surface. Gadopentetate dimeglumine did not produce selective enhancement of the inner surface of the stomach. CONCLUSION: Mangafodipir trisodium preferentially enhances the inner surface of the stomach on MR images acquired in swine and, therefore, may have potential for use as a contrast agent at MR imaging of the human stomach.

AB - PURPOSE: To evaluate mangafodipir trisodium as a potential contrast agent at magnetic resonance (MR) imaging of the stomach. MATERIALS AND METHODS: Mangafodipir trisodium was injected intravenously into three swine at a dose of 5 μmol per kilogram of body weight. For comparison, gadopentetate dimeglumine was injected into three other swine at a dose of 0.1 mmol per kilogram of body weight. T1-weighted three-dimensional MR images were acquired in all six swine at 1.5 T before and approximately 10, 15, 20, 25, 30, and 40 minutes after contrast material administration. Extracted stomach specimens were imaged at 3.0 T. In vivo and ex vivo images were evaluated visually and quantitatively for contrast enhancement of the stomach, and in vivo images were evaluated for the presence of reflux from the duodenum. RESULTS: Mangafodipir trisodium produced prolonged and selective enhancement of the inner surface of the stomach, in contrast to the more general enhancement seen with gadopentetate dimeglumine, and reflux from the duodenum could not account for this selective enhancement. Ex vivo images confirmed that T1 enhancement in the stomach wall with mangafodipir trisodium was limited to the inner surface. Gadopentetate dimeglumine did not produce selective enhancement of the inner surface of the stomach. CONCLUSION: Mangafodipir trisodium preferentially enhances the inner surface of the stomach on MR images acquired in swine and, therefore, may have potential for use as a contrast agent at MR imaging of the human stomach.

KW - Animals

KW - Experimental study

KW - Magnetic resonance (MR), contrast media

KW - Stomach, MR

KW - Stomach, mucosa

UR - http://www.scopus.com/inward/record.url?scp=2942733329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942733329&partnerID=8YFLogxK

U2 - 10.1148/radiol.2321030876

DO - 10.1148/radiol.2321030876

M3 - Article

VL - 232

SP - 160

EP - 163

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 1

ER -